Hansen Medical, Inc.
Hansen Medical
800 East Middlefield Road
Mountain View,
CA 94043
Phone: 650-404-5800
Fax: 650-404-5901
Web Site: http://www.hansenmedical.com
| REUTERS ABRIDGED BUSINESS SUMMARY | |
| Hansen Medical, Inc. develops, manufactures, and markets medical robotics designed for accurate positioning, manipulation, and stable control of catheters and catheter-based technologies. It focuses on electrophysiology procedures for the diagnosis and treatment of patients, who suffer from abnormal heart rhythms, or arrhythmias, such as atrial fibrillation. The company offers Sensei Robotic Catheter system, which is designed to allow physicians to navigate flexible catheters with stability and control in interventional procedures; disposable Artisan catheter and guide catheter assembly, which consists of a telescoping set of control catheters that are integrated to provide the desired motion of the tip of a diagnostic or therapeutic catheter; and CoHesion 3D Visualization Module, a software interface between its Sensei system and the St. Jude Medical EnSite system to provide physicians with 3D visualization to move a catheter in heart, as well as increase control over placement of the catheter in specific locations. It serves patients, physicians, hospitals, and third-party payors. The company sells its products through direct sales force in the United States; and through direct sales force and distributors primarily in the European Union, as well as internationally. The company has a joint development agreement and a co-marketing agreement with Atrial Fibrillation Division of St. Jude Medical, Inc.; and collaboration agreements with Royal Philips Electronics and GE Healthcare Ltd. Hansen Medical, Inc., formerly known as AutoCath, Inc., was founded in 2002 and is headquartered in Mountain View, California. |
|
| Key Statistics | More from Reuters
Expanded Business Description |
| |
| REUTERS ABRIDGED FINANCIAL SUMMARY | |
| | Pay | Exercised | Dr. Frederic H. Moll M.D., 57
Co-Founder, Chief Exec. Officer, Pres |
$
350.00K | N/A | Mr. Robert G. Younge , 58
Co-Founder and Chief Technical Officer |
$
185.00K | N/A | Mr. Steven M. Van Dick , 54
Chief Financial Officer, Principal Accounting Officer and VP of Fin. & Admin. |
$
247.00K |
$
221.00K | Mr. Christopher Sells , 46
Sr. VP of Commercial Operations |
$
327.00K | N/A | Mr. Daniel T. Wallace , 42
Co-Founder and VP of Regulatory & Clinical Affairs |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.07 (2.78%)
Reuters offers more in-depth
